{"id": "1387319000246493184", "creation": 1619597599.0, "user_id": "50265238", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 58, "reply_count": 2, "like_count": 100, "quote_count": 6}}, "text": "NEW Research: #Safety and #immunogenicity of one versus two doses of the #COVID19 #vaccine BNT162b2 for patients with #cancer: interim analysis of a prospective observational study https://t.co/bMQfOPJBgA", "first_save": 1634559108.199414, "hashtags": ["#SAFETY", "#IMMUNOGENICITY", "#COVID19", "#VACCINE", "#CANCER"]}